Why Enzo Biochem Stock Is Skyrocketing After Hours
Enzo Biochem Inc (NYSE: ENZ) shares are soaring in extended trading Thursday after the company agreed to sell its clinical lab to Laboratory Corporation Of America</
Credit Suisse Maintains Outperform on Laboratory Corp, Lowers Price Target to $288
Credit Suisse analyst Jonathan Yong maintains Laboratory Corp (NYSE:LH) with a Outperform and lowers the price target from $304 to $288.
Ovia Health Expands Digital Platform Capabilities To Include Menopause Tracking
Digital platform expansion provides women access to resources for their unique health care needs
Ovia Health, a trusted digital health platform for women and families, today announced the expansion of its Ovia® app,
Mizuho Maintains Buy on Laboratory Corp, Raises Price Target to $277
Mizuho analyst Ann Hynes maintains Laboratory Corp (NYSE:LH) with a Buy and raises the price target from $250 to $277.
Labcorp FY23 Adj. EPS Outlook $16.00 – $18.00 Vs. $17.71 Estimate, Free Cash Flow $1.0B – $1.2B
2023 Guidance
The following guidance assumes foreign exchange rates effective as of Dec. 31, 2022, for the full year. Enterprise level guidance includes the estimated impact from currently anticipated capital
Laboratory Corp Q4 Adj. EPS $4.14 Beats $4.11 Estimate, Sales $3.67B Miss $3.74B Estimate
Laboratory Corp (NYSE:LH) reported quarterly earnings of $4.14 per share which beat the analyst consensus estimate of $4.11 by 0.73 percent. This is a 38.85 percent decrease over earnings of $6.77 per share from the same
Earnings Scheduled For February 16, 2023
Companies Reporting Before The Bell
• RELX (NYSE:RELX) is estimated to report earnings for its Fiscal Year 2022.
• Coca-Cola Europacific (NASDAQ:CCEP) is expected to report earnings for its Fiscal Year 2022.
Baird Maintains Outperform on Laboratory Corp, Raises Price Target to $285
Baird analyst Eric Coldwell maintains Laboratory Corp (NYSE:LH) with a Outperform and raises the price target from $270 to $285.
6 Analysts Have This to Say About Laboratory Corp
Laboratory Corp (NYSE:LH) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…
Morgan Stanley Maintains Overweight on Laboratory Corp, Raises Price Target to $303
Morgan Stanley analyst Ricky Goldwasser maintains Laboratory Corp (NYSE:LH) with a Overweight and raises the price target from $290 to $303.